About Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency
Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency is a rare disease catalogued by Orphanet (ORPHA:217467). It is associated with the HRG gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency trials.
Search ClinicalTrials.gov for "Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency" or filter by Orphanet code ORPHA:217467 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency. Updated daily.